https://www.cancer.gov/research/participate/clinical-trials-search/v?id=NCI-2023-09679&r=1
A Study of Nemtabrutinib Plus Venetoclax vs Venetoclax + Rituximab (VR) in Second-line (2L) +...
A Study of Nemtabrutinib Plus Venetoclax vs Venetoclax + Rituximab (VR) in Second-line (2L) + Relapsed/Refractory (R/R) Chronic Lymphocytic Leukemia/Small...
a studysecond linenemtabrutinibplusvenetoclax